Though it is clear that genomic variability plays an integral role in accounting for pain sensitivity, controversy exists over which genes are involved. While recent data suggest a ''protective" (i.e., less pain) haplotype in the GTP cyclohydrolase (GCH1) gene, other research has failed to confirm this association. Possibly, the effects of single nucleotide polymorphisms (SNPs) vary depending on the pain task. The current investigation analyzed the association of five previously identified GCH1 SNPs with ratings of pain induced by topical high concentration (10%) capsaicin applied to the skin of 39 healthy human volunteers. Each of the GCH1 polymorphisms was associated with lower pain ratings. When combined, three of the five accounted for a surprisingly high 35% of the inter-individual variance in pain ratings. We conclude that SNPs of the GCH1 gene may profoundly affect the ratings of pain induced by capsaicin. Ó
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Introduction
A growing body of research suggests that genetic variability at a number of loci contributes to individual differences in pain sensitivity [7, 15] . GTP cyclohydrolase (GCH1), recently implicated in shaping pain responses in rodents and humans, regulates production of g(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4), an essential cofactor for the synthesis of dopamine, serotonin, and nitric oxide. To date, three studies have evaluated GCH1's role in nociceptive processing. In the initial report, Tegeder et al.
[18] discovered a haplotype associated with reduced ratings of experimental pain stimuli in normal volunteers, and a favorable outcome with regard to long-term pain reduction in patients that underwent lumbar disc surgery. However, Kim and Dionne [10] failed to replicate significant associations between the same GCH1 genomic variants and pain responses, both in assessment of experimental pain and in a postoperative third-molar dental pain model. The most recent assessment, performed by authors that presented the initial findings, indicates that carriers of the protective haplotype, relative to non-carriers, reported decreased sensitivity to mechanical stimulation following freeze lesion. Individuals that expressed the protective haplotype further showed an increased thermal pain threshold (less hyperalgesia) on capsaicin-treated skin, when compared to those that exhibited the more common alleles [17] . One potential explanation for the discrepant findings could be the use of differing postoperative pain assessments and experimental stimuli [8] . The recent findings by Tegeder (2008) may suggest a mechanistic link between the experimentally induced sensitized skin and the protective effects of the GCH1 haplotype. Our group possessed existing data on a small cohort of subjects undergoing assessment of pain responses following topical application of capsaicin. We sought to characterize the association of previously identified GCH1 SNPs and ratings of capsaicin pain intensity in this sample of healthy participants. The present study is distinctive in that we tested pain to capsaicin directly over an extended period of time (90 min). This paradigm yielded positive results despite a relatively small number of subjects, thus suggesting that this test may have a particularly strong ability to distinguish effects.
